TNF Pharmaceuticals, Inc.

(NASDAQ) TNFA

Current PriceN/A

Market CapN/A

Since IPO (2021)-100%

5 Year-100%

1 Year-81%

1 Month+10%

TNF Pharmaceuticals, Inc. Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$6.91M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

TNFA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TNF Pharmaceuticals, Inc.

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Christopher C. Chapman, Jr., MD

Website

tnfpharma.com

Headquarters

New York City, NY 21205, US

TNFA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-68%

Return on Capital

-28%

Return on Assets

-28%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-0.67%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$10.17M

EBITDA

$20.57M

Operating Cash Flow

$8.98M

Capital Expenditure

$3.00

Free Cash Flow

$8.98M

Cash & ST Invst.

$8.52M

Total Debt

$10.58K

TNF Pharmaceuticals, Inc. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$1.80M

+81.2%

EBITDA

$1.80M

N/A

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$3.81M

-70.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-28.24%

N/A

Return on Invested Capital

-27.63%

N/A

Free Cash Flow

$2.07M

+22.6%

Operating Cash Flow

$2.07M

+22.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CRVOCervoMed Inc.

CRVOCervoMed Inc.$3.71+0.54%

IMVIFIMV Inc.

IMVIFIMV Inc.$0.00+0.00%

APGNApexigen, Inc.

APGNApexigen, Inc.$0.39+8.48%

CYCCCyclacel Pharmaceuticals, Inc.

CYCCCyclacel Pharmaceuticals, Inc.$6.37-5.98%

TVRDTvardi Therapeutics, Inc.

TVRDTvardi Therapeutics, Inc.$3.14-0.32%

TSBXTurnstone Biologics Corp.

TSBXTurnstone Biologics Corp.$0.35+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About TNFA

What is the current price of TNF Pharmaceuticals, Inc.?

TNF Pharmaceuticals, Inc. is trading at N/A per share.

What is the 52-week range for TNF Pharmaceuticals, Inc.?

Over the past 52 weeks, TNF Pharmaceuticals, Inc. has traded between N/A and N/A.

How much debt does TNF Pharmaceuticals, Inc. have?

As of the most recent reporting period, TNF Pharmaceuticals, Inc. reported total debt of N/A.

How much cash does TNF Pharmaceuticals, Inc. have on hand?

TNF Pharmaceuticals, Inc. reported $986,996 in cash and cash equivalents in its most recent financial results.

What is TNF Pharmaceuticals, Inc.’s dividend yield?

TNF Pharmaceuticals, Inc. does not currently have a dividend yield.

TNF Pharmaceuticals, Inc.

TNF Pharmaceuticals, Inc. Financials at a Glance

TNFA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About TNF Pharmaceuticals, Inc.

TNFA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

TNF Pharmaceuticals, Inc. Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TNFA

What is the current price of TNF Pharmaceuticals, Inc.?

What is the 52-week range for TNF Pharmaceuticals, Inc.?

How much debt does TNF Pharmaceuticals, Inc. have?

How much cash does TNF Pharmaceuticals, Inc. have on hand?

What is TNF Pharmaceuticals, Inc.’s dividend yield?

Premium Investing Services